To evaluate the effects of TS inhibition melanoma cell lines IGR1 and IGR37 were incubated for 24 h with two different de novo thymidine synthesis pathways targeting drugs MTX (10 μmol/L) and FdUrd (10 μmol/L). This evidence concerns the gene TYMS and melanoma.